All posts by medical

Greys Anatomy: Why The Show Should End (& 5 Why Fans Want It To Keep Going) – Screen Rant

Grey's Anatomy is one of the longest lasting shows in television. Why should it end now, and why do it's fans want the show keep going?

Grey's Anatomy has been on the air for 17 seasons, and some say it is time to call it quits. Ellen Pompeo has even hinted that this might be the final season of the show and the direction it's taking doesn't instill confidence that they have more seasons planned for the future. Some fans are relieved that it will finally be over, while others wish that they would keep the magic alive.

RELATED:Grey's Anatomy: 10 Things About Meredith That Make No Sense

There are reasons why it could go either way, especially when analyzing the direction of the show in recent years. No decision has been made as of yet, but here's to hoping that Grey's Anatomy never ends despite some of the telling signs!

It has become painfully obvious that they are starting to run out of ideas for the show, especially as some recurring themes keep popping up throughout the series.

Fans are just waiting for them to kill off the next character in the series and find out which relationship is going to end in heartbreak. Many want the show to continue, but with this repetition some find themselves refusing to watch anymore as they grow bored of the monotony.

Meredith has a lot ahead of her, and although she has won a Harper Avery Award, she has the potential to win a Catherine Fox award next.

Her mind is full of great ideas and advice that leavesfans wanting to explore the possibilities and watch as she continues to grow. Ellen Pompeo might have had enough, but Meredith Grey sure hasn't as her efforts to make advancements have seemed to stall.

The focus has begun to shift from medicine to more political ventures. Fans watched Meredith Grey pick up trash for a while in an emotional twist after she committed insurance fraud when they could have focused on other medical advancements.

Yes, it is important for a show as big as this to share information on real-world issues, but they don't have to become 90% of the plot.

There are several developing relationships in Grey's Anatomy, with Link and Amelia welcoming a new child into their home, and between Maggie and Winston who were old colleagues. Chemistry is even evident between Jo and Jackson, which fans want to see grow into something more, because she deserves it after the way Alex Karev left her.

RELATED:Which Grey's Anatomy Character Is Your Soulmate, Based On Your Zodiac?

A single season won't be enough to cover all of the relationships and the paths they will take in the future, which is why it can't end. They all deserve a happily ever after, and right now Grey's Anatomy just isn't giving it to them.

Owen has gone through numerous breakups and failed marriages with Cristina Yang and Amelia Shepard, but now Teddy has even broken his heart.

Yes, Owen finally has the children he always wanted, although fans can't watch him lose another happy ending once again. They all thought that Teddy was the one and after her actions, they see her true colors and her feelings toward Owen.

New medical advancements are being made every day as doctors and scientists work hard to make the world a healthierplace. While the show has steered clear of featuring these, there are so many for it to choose from like artificial intelligence and VR technology to complete procedures.

It is part of why the show is so exciting, as they bring up hot topics and advancements that fans would otherwise know nothing about.

Only three members of the original cast are left, and they are Miranda Bailey, Richard Webber, and of course, Meredith Grey herself. Fans have watched characters die, move, or disappear into thin air as they choose to start a new life away from Seattle.

RELATED:Grey's Anatomy: 10 Most Memorable Patients, Ranked By Likability

The show has been around a long time and the remaining cast is growing in age, which means it might be time for them to retire and move on with their lives. Fans always knew there would be an end to their story and now seems like the perfect time to make that happen.

Meredith has three children of her own who would now be old enough to play a bigger part in the series, and even down the road. They haven't been used much at all, but there is always room for the show to grow by giving them bigger parts to play so Meredith can make more questionable parenting choices.

It is something that fans have been looking forward to for ages, and some even hope for a spin-off series to be made down the line, showing their own success in the medical field.

Alex Karev's storyline was ruined the moment that he left Jo without a single word and decided to start a new life with Izzie and their kids.

It tarnished his character's reputation, as there were so many other ways he could have left the show, and put a bad taste in fans' mouths, which is one they hope to never taste again. Unfortunately, it seems they are even doing the same thing with Teddy and her cheating scandal, and it goes to show that it needs to end before anyone else's storyline is changed for the worse.

Cristina Yang will never be forgotten despite her leaving after Season 10, and fans have been begging for her to make a return.

The actress behind this character, Sandra Oh, has stated she has left Grey's Anatomy far behind her, but fans are still holding onto this dream. The show can't end until she is convinced to make one more reappearance so the show can feel complete in the eyes of fans.

NEXT:Grey's Anatomy 10 Famous Actors You Forgot Were In The Series

Next Teen Wolf: Main Characters First And Last Lines

Rebecca O'Neill is a reader and writer based in Ohio, near the heart of the CLE. She enjoys starting fires in her kitchen and collecting pins when she's not writing for Valnet, Inc. as an Organic List Writer. She writes for her blog, Creative Measures, and works towards the completion of her fantasy novel.

Read this article:
Greys Anatomy: Why The Show Should End (& 5 Why Fans Want It To Keep Going) - Screen Rant

‘Grey’s Anatomy’: The 5 Highest-Rated Episodes Before TR Knight’s Exit as George O’Malley, According To IMDb – Showbiz Cheat Sheet

Greys Anatomy is one of the longest-running shows on TV. As such, the medical dramas seen a reshuffling of stars through the years. Actors have been joining the cast and bidding farewell to the fictional Seattle hospital on and off since the early days of Greys Anatomy.

T.R. Knight, the actor who played Dr. George OMalley, made one of the most memorable exits from Greys Anatomy. An original surgical intern at Seattle Grace Hospital, Knights departure meant his character would no longer be on screen with Dr. Meredith Grey (Ellen Pompeo), Dr. Alex Karev (Justin Chambers), Dr. Cristina Yang (Sandra Oh), or Dr. Izzie Stevens (Katherine Heigl).

Although thered been behind-the-scenes drama involving Isaiah Washington (Dr. Preston Burke), the actor insisted it had nothing to do with his exit. Knight explained the reason he left during a 2009 interview with Entertainment Weekly.

My five-year experience proved to me that I could not trust any answer that was given [about George], he said. And with respect, Im going to leave it at that.

There just comes a time when its so clear that moving on is the best decision, he added.

Knights departure meant his character had to be written off somehow. Ultimately, the writers behind Greys Anatomy killed George off in a dramatic end to the shows fifth season.

RELATED: Kate Walsh on Leaving Greys Anatomy for Private Practice: It Felt Like the Right Time To Go

In this episode leading up to Knights exit, his character George has a terrible day in the Emergency Room. He helps with incoming trauma victims and it seems to George all of his patients die.

After some encouraging words from Dr. Owen Hunt (Kevin McKidd), George celebrates the wedding of Dr. Meredith Grey (Ellen Pompeo) and Dr. Derek Shepherd (Patrick Dempsey).In a twist, Meredith and Dereks wedding becomes a ceremony for Dr. Alex Karev (Justin Chambers) and Dr. Izzie Stevens (Katherine Heigl).

As Izzie struggles to walk down the aisle, George gets up from the crowd to help her the rest of the way. Nearly 1,500 IMDb users have rated the episode, giving it an average score of 9.3 stars out of 10.

RELATED:The Sneaky Way Shonda Rhimes Helped Sandra Oh Nail Her Greys Anatomy Audition

Tied with What a Difference a Day Makes, the season 2 finale also boasts a 9.3-star IMDb rating. After the fiasco with Denny Duquette (Jeffrey Dean Morgan), Dr. Richard Webber (James Pickens Jr.) punishes the interns by forcing them to plan a prom for his niece. George faces his feelings about Dr. Callie Torres (Sara Ramirez) and Dennys condition takes a turn.

RELATED:Patrick Dempsey Was Convinced Shonda Rhimes Didnt Want Him to Play Derek Shepherd When He Auditioned for Greys Anatomy

A storyline spanning two episodes, As We Know It and Its the End of the World both have 9.5 stars out of 10 on IMDb. In these back-to-back episodes, the doctors at Seattle Grace had an intense day at work. A patient arrived at the hospital with a bomb inside of him that could go off at any moment. After a paramedic fled, Meredith took over, shoving her hand inside the patients body to prevent the bomb from detonating.

RELATED:Greys Anatomy: Patrick Dempsey Immediately Had a Great Connection with Ellen Pompeo Heres Why

Knights last episode as a regular cast member on Greys Anatomy ranks highest with 9.6 stars out of 10. In the season five finale, George steps in front of a bus to save someone. Due to the severity of his injuries, no one at the hospital knows his identity.

That is until Meredith figures out its George thanks to him writing 007 a throwback to his nickname in the pilot on her palm. The doctors do everything they can to save George but he dies.

Knight reprised his role as OMalley in a 2020 episode of Greys Anatomy during a dream sequence of Merediths. Watch Greys Anatomy on Netflix and catch new episodes every Thursday night on ABC.

RELATED: Greys Anatomy Photos From the Pilot To Get Fans Excited for Season 17

Read the rest here:
'Grey's Anatomy': The 5 Highest-Rated Episodes Before TR Knight's Exit as George O'Malley, According To IMDb - Showbiz Cheat Sheet

Osteoarthritis Therapeutics Market, 2025 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global osteoarthritis therapeutics market grew at a CAGR of around 8% during 2014-2019.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan.

Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the market growth.

Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth.

Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Looking forward, the publisher expects the global osteoarthritis therapeutics market to continue its moderate growth during the next five years.

Key Questions Answered in This Report:

Key Market Segmentation:

Breakup by Anatomy Type:

Breakup by Drug Type:

Breakup by Route of Administration:

Breakup by End User:

Breakup by Region:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/dudyxn

More:
Osteoarthritis Therapeutics Market, 2025 - ResearchAndMarkets.com - Business Wire

Global Neuroscience Market Estimated To Record Double-Digit Growth Over 2020-2026 Zion Market Research – Farming Sector

According to the report, global demand for Global Neuroscience Market Estimated To Record Double-Digit Growth Over 2020-2026 Zion Market Research

The market research report titled Neuroscience Market 2020 and published by Zion Market Research provides an insightful comprehension about the growth aspects, dynamics, and working of the global Neuroscience Market. The report entails details about the market with data collected over the years with its wide-ranging analysis. It also comprises the competitive landscape within the market together with a detailed evaluation of the leading players within the globalNeuroscience Market. In addition, it sheds light on the profiles of the key vendors/manufacturers comprising thorough assessment of the market share, production technology, market entry strategies, revenue forecasts, and so on. Further, the report will encompass the fundamental strategic activities such as product developments, mergers & acquisitions, launches, events, partnerships, collaborations, and so on. Apart from this, it will also present the new entrants contributing their part in the market growth.

THE SALE WORTH WAITING FOR IS BACK

Year-End-Sale 2020 Up to 30% OFF 31st December 2020

Global Neuroscience Market:Competitive Players

Alpha Omega, Axion Biosystems, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Neurotar Ltd., Newport Corporation, Plexon Inc., Scientifica Ltd.

The Neuroscience Market report also entails exhaustive examination of the key factors likely to propel or restrict the expansion of the global Neuroscience Market during the forecast period in addition to the most recent and promising future trends in the market. Moreover, the report uses SWOT analysis and other methodologies to analyze the numerous segments [Product, Applications, End-Users, and Major Regions] of the global Neuroscience Market. Furthermore, it comprises valuable understanding about the segments like their growth potential, market share, and developments. It also evaluates the market on the basis of its major geographical regions [Latin America, North America, Asia Pacific, Middle & East Africa, and Europe]. It entails quantitative and qualitative facets of the market in association to each country and region enlisted in the report.

Promising Regions & Countries Mentioned In The Neuroscience Market Report:

Request Free Sample Report of Neuroscience Market Report @https://www.zionmarketresearch.com/sample/neuroscience-market

The Neuroscience Market report also stipulates the computed expected CAGR of the market estimated on the basis of the existing and previous records concerning the global Neuroscience Market. The report analyzes the market with the aim of being capable to get a clear picture of prevailing and anticipated growth patterns of the market. Furthermore, it entails the impact of numerous federal policies and rules on the growth and dynamics of the market during the forecast period. The thorough assessment put forth by our analysts assist to get more profound acquaintance of global markets and related industries. In addition, the report encompasses various tactics to discover the weaknesses, opportunities, risks, and strengths having the potential to impact the global market expansion.

Impact of COVID-19 (Coronavirus):The report will also entail a dedicated section assessing the influence of COVID-19 on the expansion of the global Neuroscience Market during the coming period.

Report Customization: Clients can request for customization of report as per their need for additional data.

Apart from this, our team will be accessible around the clock to our clients for any kind of assistance.

Download Free PDF Report Brochure @https://www.zionmarketresearch.com/requestbrochure/neuroscience-market

Key Details & USPs of the Existing Report Study:

Request coronavirus impact analysis on sectors and market

Request impact analysis on this market @https://www.zionmarketresearch.com/custom/2776?covid19=true

What Reports Provides

Also, Research Report Examines:

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

Email:[emailprotected]

Website:www.zionmarketresearch.com

Link:
Global Neuroscience Market Estimated To Record Double-Digit Growth Over 2020-2026 Zion Market Research - Farming Sector

Neuroscience Market Manufacturers Analysis And Industry Insights 2020-2026 | GE Healthcare, Siemens Healthineers, Noldus Information Technology,…

The Global Neuroscience Market research report delivers valuable insights into the existing and prospective trends observed in the industry, to give the readers a holistic view of market offerings, helping them recognize promising investment opportunities and other factors driving the revenue generation and overall profitability. The Neuroscience Market report offers an extensive investigation of all the relevant market features affecting its progress on both regional and global scales, while evaluating market drivers, restraints, hurdles, obstacles, and industry-centric trends. The report further deduces key trends observed in the historical data, along with upstream and downstream evaluation of major participants.

The Neuroscience market research focuses on the market structure along with various factors (positive and negative) that influence the market growth. The study contains a precise evaluation of the Neuroscience market, including growth rate, current market scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses.

Major players covered in this report:

GE HealthcareSiemens HealthineersNoldus Information TechnologyMightex BioscienceThomas RECORDING GmbHBlackrock MicrosystemsTucker-Davis TechnologiesPlexonPhoenix Technology GroupNeuroNexusAlpha Omega

Get a Sample Copy of the report @https://www.reporthive.com/request_sample/2298403

Neuroscience market by Types:

Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Others

Neuroscience market by Applications:

Hospitals, Diagnostic Laboratories, Research Institutes, Others

Key questions answered in this research study What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Neuroscience? Who are the global key manufacturers of Neuroscience industry? How are their operating situation (capacity, production, price, cost, gross and revenue)? What are the types and applications of Neuroscience? What is the market share of each type and application? What are the upstream raw materials and manufacturing equipment of Neuroscience? What is the manufacturing process of Neuroscience? Economic impact on Neuroscience industry and development trend of Neuroscience industry. What will the Neuroscience market size and the growth rate be in 2025? What are the key factors driving the global Neuroscience industry? What are the key market trends impacting the growth of the Neuroscience market? What are the Neuroscience market challenges to market growth? What are the Neuroscience market opportunities and threats faced by the vendors in the global Neuroscience market?

Major regions covered in the report:North America [U.S., Canada, Mexico]Europe [Germany, UK, France, Italy, Rest of Europe]Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]South America [Brazil, Argentina, Rest of Latin America]Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

For More Information or Query or Customization Before Buying, Visit at -:https://www.reporthive.com/request_customization/2298403

Detailed TOC of Global Neuroscience market:1 Market Overview1.1Neuroscience market Introduction1.2 Market Analysis by Type1.2.1 Type 11.2.2 Type 21.3 Market Analysis by Application1.3.1 Application 11.3.2 Application 21.4 Market Analysis by Region1.4.1 United States Market States and Outlook (2014-2026F)1.4.2 Europe Market States and Outlook (2014-2026F)1.4.3 China Market States and Outlook (2014-2026F)1.4.4 Japan Market States and Outlook (2014-2026F)1.4.5 Southeast Asia Market States and Outlook (2014-2026F)1.5 Market Dynamics and Development1.5.1 Merger, Acquisition and New Investment1.5.2 Market SWOT Analysis1.5.3 Drivers1.5.4 Limitations1.5.5 Opportunities and Development Trends1.6 Global Market Size Analysis from 2014 to 20261.6.1 Global Market Size Analysis from 2014 to 2026 by Consumption Volume1.6.2 Global Market Size Analysis from 2014 to 2026 by Value1.6.3 Global Price Trends Analysis from 2014 to 20262 Global Neuroscience market Competition by Types, Applications, and Top Regions and Countries2.1 Global Neuroscience market(Volume and Value) by Type2.1.1 Global Neuroscience market Consumption and Market Share by Type (2014-2020)2.1.2 Global Neuroscience market Revenue and Market Share by Type (2014-2020)2.2 Global Neuroscience market(Volume and Value) by Application2.2.1 Global Neuroscience market Consumption and Market Share by Application (2014-2020)2.2.2 Global Neuroscience market Revenue and Market Share by Application (2014-2020)2.3 Global Neuroscience market(Volume and Value) by Region2.3.1 Global Neuroscience market Consumption and Market Share by Region (2014-2020)2.3.2 Global Neuroscience market Revenue and Market Share by Region (2014-2020)Continued.

About us:

Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.

Link:
Neuroscience Market Manufacturers Analysis And Industry Insights 2020-2026 | GE Healthcare, Siemens Healthineers, Noldus Information Technology,...

Why Do We Dream? A New Theory on How It Protects Our Brains – TIME

When he was two years old, Ben stopped seeing out of his left eye. His mother took him to the doctor and soon discovered he had retinal cancer in both eyes. After chemotherapy and radiation failed, surgeons removed both his eyes. For Ben, vision was gone forever.

But by the time he was seven years old, he had devised a technique for decoding the world around him: he clicked with his mouth and listened for the returning echoes. This method enabled Ben to determine the locations of open doorways, people, parked cars, garbage cans, and so on. He was echolocating: bouncing his sound waves off objects in the environment and catching the reflections to build a mental model of his surroundings.

Echolocation may sound like an improbable feat for a human, but thousands of blind people have perfected this skill, just like Ben did. The phenomenon has been written about since at least the 1940s, when the word echolocation was first coined in a Science article titled Echolocation by Blind Men, Bats, and Radar.

How could blindness give rise to the stunning ability to understand the surroundings with ones ears? The answer lies in a gift bestowed on the brain by evolution: tremendous adaptability.

Whenever we learn something new, pick up a new skill, or modify our habits, the physical structure of our brain changes. Neurons, the cells responsible for rapidly processing information in the brain, are interconnected by the thousandsbut like friendships in a community, the connections between them constantly change: strengthening, weakening, and finding new partners. The field of neuroscience calls this phenomenon brain plasticity, referring to the ability of the brain, like plastic, to assume new shapes and hold them. More recent discoveries in neuroscience suggest that the brains brand of flexibility is far more nuanced than holding onto a shape, though. To capture this, we refer to the brains plasticity as livewiring to spotlight how this vast system of 86 billion neurons and 0.2 quadrillion connections rewires itself every moment of your life.

Neuroscience used to think that different parts of the brain were predetermined to perform specific functions. But more recent discoveries have upended the old paradigm. One part of the brain may initially be assigned a specific task; for instance, the back of our brain is called the visual cortex because it usually handles sight. But that territory can be reassigned to a different task. There is nothing special about neurons in the visual cortex: they are simply neurons that happen to be involved in processing shapes or colors in people who have functioning eyes. But in the sightless, these same neurons can rewire themselves to process other types of information.

Mother Nature imbued our brains with flexibility to adapt to circumstances. Just as sharp teeth and fast legs are useful for survival, so is the brains ability to reconfigure. The brains livewiring allows for learning, memory, and the ability to develop new skills.

In Bens case, his brains flexible wiring repurposed his visual cortex for processing sound. As a result, Ben had more neurons available to deal with auditory information, and this increased processing power allowed Ben to interpret soundwaves in shocking detail. Bens super-hearing demonstrates a more general rule: the more brain territory a particular sense has, the better it performs.

Recent decades have yielded several revelations about livewiring, but perhaps the biggest surprise is its rapidity. Brain circuits reorganize not only in the newly blind, but also in the sighted who have temporary blindness. In one study, sighted participants intensively learned how to read Braille. Half the participants were blindfolded throughout the experience. At the end of the five days, the participants who wore blindfolds could distinguish subtle differences between Braille characters much better than the participants who didnt wear blindfolds. Even more remarkably, the blindfolded participants showed activation in visual brain regions in response to touch and sound. When activity in the visual cortex was temporarily disrupted, the Braille-reading advantage of the blindfolded participants went away. In other words, the blindfolded participants performed better on the touch-related task because their visual cortex had been recruited to help. After the blindfold was removed, the visual cortex returned to normal within a day, no longer responding to touch and sound.

But such changes dont have to take five days; that just happened to be when the measurement took place. When blindfolded participants are continuously measured, touch-related activity shows up in the visual cortex in about an hour.

What does brain flexibility and rapid cortical takeover have to do with dreaming? Perhaps more than previously thought. Ben clearly benefited from the redistribution of his visual cortex to other senses because he had permanently lost his eyes, but what about the participants in the blindfold experiments? If our loss of a sense is only temporary, then the rapid conquest of brain territory may not be so helpful.

And this, we propose, is why we dream.

In the ceaseless competition for brain territory, the visual system has a unique problem: due to the planets rotation, all animals are cast into darkness for an average of 12 out of every 24 hours. (Of course, this refers to the vast majority of evolutionary time, not to our present electrified world.) Our ancestors effectively were unwitting participants in the blindfold experiment, every night of their entire lives.

So how did the visual cortex of our ancestors brains defend its territory, in the absence of input from the eyes?

We suggest that the brain preserves the territory of the visual cortex by keeping it active at night. In our defensive activation theory, dream sleep exists to keep neurons in the visual cortex active, thereby combating a takeover by the neighboring senses. In this view, dreams are primarily visual precisely because this is the only sense that is disadvantaged by darkness. Thus, only the visual cortex is vulnerable in a way that warrants internally-generated activity to preserve its territory.

In humans, sleep is punctuated by rapid eye movement (REM) sleep every 90 minutes. This is when most dreaming occurs. (Although some forms of dreaming can occur during non-REM sleep, such dreams are abstract and lack the visual vividness of REM dreams.)

REM sleep is triggered by a specialized set of neurons that pump activity straight into the brains visual cortex, causing us to experience vision even though our eyes are closed. This activity in the visual cortex is presumably why dreams are pictorial and filmic. (The dream-stoking circuitry also paralyzes your muscles during REM sleep so that your brain can simulate a visual experience without moving the body at the same time.) The anatomical precision of these circuits suggests that dream sleep is biologically importantsuch precise and universal circuitry rarely evolves without an important function behind it.

The defensive activation theory makes some clear predictions about dreaming. For example, because brain flexibility diminishes with age, the fraction of sleep spent in REM should also decrease across the lifespan. And thats exactly what happens: in humans, REM accounts for half of an infants sleep time, but the percentage decreases steadily to about 18% in the elderly. REM sleep appears to become less necessary as the brain becomes less flexible.

Of course, this relationship is not sufficient to prove the defensive activation theory. To test it on a deeper level, we broadened our investigation to animals other than humans. The defensive activation theory makes a specific prediction: the more flexible an animals brain, the more REM sleep it should have to defend its visual system during sleep. To this end, we examined the extent to which the brains of 25 species of primates are pre-programmed versus flexible at birth. How might we measure this? We looked at the time it takes animals of each species to develop. How long do they take to wean from their mothers? How quickly do they learn to walk? How many years until they reach adolescence? The more rapid an animals development, the more pre-programmed (that is, less flexible) the brain.

As predicted, we found that species with more flexible brains spend more time in REM sleep each night. Although these two measuresbrain flexibility and REM sleepwould seem at first to be unrelated, they are in fact linked.

As a side note, two of the primate species we looked at were nocturnal. But this does not change the hypothesis: whenever an animal sleeps, whether at night or during the day, the visual cortex is at risk of takeover by the other senses. Nocturnal primates, equipped with strong night vision, employ their vision throughout the night as they seek food and avoid predation. When they subsequently sleep during the day, their closed eyes allow no visual input, and thus, their visual cortex requires defense.

Dream circuitry is so fundamentally important that it is found even in people who are born blind. However, those who are born blind (or who become blind early in life) dont experience visual imagery in their dreams; instead, they have other sensory experiences, such as feeling their way around a rearranged living room or hearing strange dogs barking. This is because other senses have taken over their visual cortex. In other words, blind and sighted people alike experience activity in the same region of their brain during dreams; they differ only in the senses that are processed there. Interestingly, people who become blind after the age of seven have more visual content in their dreams than those who become blind at younger ages. This, too, is consistent with the defensive activation theory: brains become less flexible as we age, so if one loses sight at an older age, the non-visual senses cannot fully conquer the visual cortex.

If dreams are visual hallucinations triggered by a lack of visual input, we might expect to find similar visual hallucinations in people who are slowly deprived of visual input while awake. In fact, this is precisely what happens in people with eye degeneration, patients confined to a tank-respirator, and prisoners in solitary confinement. In all of these cases, people see things that are not there.

We developed our defensive activation theory to explain visual hallucinations during extended periods of darkness, but it may represent a more general principle: the brain has evolved specific circuitry to generate activity that compensates for periods of deprivation. This might occur in several scenarios: when deprivation is regular and predictable (e.g., dreams during sleep), when there is damage to the sensory input pathway (e.g., tinnitus or phantom limb syndrome), and when deprivation is unpredictable (e.g., hallucinations induced by sensory deprivation). In this sense, hallucinations during deprivation may in fact be a feature of the system rather than a bug.

Were now pursuing a systematic comparison between a variety of species across the animal kingdom. So far, the evidence has been encouraging. Some mammals are born immature, unable to regulate their own temperature, acquire food, or defend themselves (think kittens, puppies, and ferrets). Others are born mature, emerging from the womb with teeth, fur, open eyes, and the abilities to regulate their temperature, walk within an hour of birth, and eat solid food (think guinea pigs, sheep, and giraffes). The immature animals have up to 8 times more REM sleep than those born mature. Why? Because when a newborn brain is highly flexible, the system requires more effort to defend the visual system during sleep.

Since the dawn of communication, dreams have perplexed philosophers, priests, and poets. What do dreams mean? Do they portend the future? In recent decades, dreams have come under the gaze of neuroscientists as one of the fields central unsolved mysteries. Do they serve a more practical, functional purpose? We suggest that dream sleep exists, at least in part, to prevent the other senses from taking over the brains visual cortex when it goes unused. Dreams are the counterbalance against too much flexibility. Thus, although dreams have long been the subject of song and story, they may be better understood as the strange lovechild of brain plasticity and the rotation of the planet.

For more information:

For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Contact us at letters@time.com.

Link:
Why Do We Dream? A New Theory on How It Protects Our Brains - TIME

Neuroscience Antibodies and Assays Market to Remain Lucrative During 2020-2026 – NeighborWebSJ

Neuroscience Antibodies and Assays Market provides an internal and external insight into Sales and Trends Forecast from 2020 to 2026:

The latest uploaded report provides informed details on how clients can improve their essential leadership capacity across Neuroscience Antibodies and Assays Industry. The use of charts and flowcharts are characterized in this report, the experts have represented the data in an unparalleled dignified manner.

This report identifies ever-changing trends in the business sector and competition with development in the CAGR during the forecast. However, the report also discusses the most recent marketing drivers that are the basis for recording, market performance, and key choices for progress and productivity.

The most important players in this report are: Abcam PlcBio-Rad Laboratories Inc.Cell Signaling Technology Inc.F. Hoffmann-La Roche Ltd.GenScript Biotech Corp.Merck KGaARockland Immunochemicals Inc.Santa Cruz Biotechnology Inc.Tecan Group Ltd.Thermo Fisher Scientific Inc.

The Neuroscience Antibodies and Assays Market Research Report presents a top to bottom data and expert analysis for the period to 2026. The report contains information on upstream raw materials, downstream interest, and value of production, as well as a number of important factors that may stimulate market development. In the same way, the report consists of Manufactures, Types, Applications, and Regions.

Go to Sample report of the Neuroscience Antibodies and Assays [emailprotected]: https://www.regalintelligence.com/request-sample/191287

Neuroscience Antibodies and Assays Primary end-users of the marketplace

Neuroscience Antibodies and Assays Market Segment according to Product Types:

The estimation period, taking into account the size of the market for the Neuroscience Antibodies and Assays, is the following:

Market Segmentation:

The Global market Neuroscience Antibodies and Assays is segmented according to the kind of item, application, and region. The examiners who write the report carefully assess all segments, their share of the total industry, the rate of income market development, and other critical variables. The segmented study prepares to invest individuals to distinguish high-growth segments of the global market Neuroscience Antibodies and Assays and see how the major segments may develop during the forecast period.

Primary Objectives of Neuroscience Antibodies and Assays market Report:

Get a Special Discount on the occasion of the New Year! https://www.regalintelligence.com/check-discount/191287

Key questions answered in this report:

We are consistently glad to help you on your inquiries: [emailprotected]

Thank You.

See the rest here:
Neuroscience Antibodies and Assays Market to Remain Lucrative During 2020-2026 - NeighborWebSJ

Health and Social Care Professionals Recognised in New Year Honours – Medscape

Editor's note, 31 December 2020: This article was updated with additional recipients.

The work of more than a hundred health and social care workers during the COVID-19 pandemic has been recognised in this year's New Year Honours.

They include a British Empire Medal (BEM) for Cath Fitzsimmons from Greater Manchester, a former palliative care nurse who came out of retirement for COVID-19.

Also awarded a BEM was Dr Azeem Alam, a junior doctor at Guy's and St Thomas' NHS Foundation Trust, who founded BiteMedicine, providing free medical education for medical students during the pandemic.

An MBE went to Jacky Coping from Suffolk, a deputy director of nursing, who initiated Face Fit Testing at the James Paget University Hospitals NHS Foundation Trust to help ensure that frontline workers were properly protected against COVID-19.

Public sector workers, including medical professionals, make up 14.8% of the list mainly for the way they responded to the pandemic.

Prime Minister Boris Johnson said: "In a year when so many have made sacrifices to protect our NHS and save people's lives, the outstanding efforts of those receiving honours today are a welcome reminder of the strength of human spirit, and of what can be achieved through courage and compassion."

Prof Paul Cosford was knighted for services to public health. Prof Cosford was lately emeritus medical director for Public Health England (PHE).

He joined PHE in 2012 after leading the national and local delivery of health protection services within the Health Protection Agency.

Among others to be honoured who'll receiveMBEs were:

Captain Emma Henderson, from Moray in Scotland, for founding Project Wingman, creating a 'first class' lounge experience in hospitals in the UK for NHS workers

Dr Fiona Dempsey, consultant in intensive care medicine and anaesthesia, Somerset NHS Foundation Trust forservices to the NHS

Dr Thomas Best, clinical director critical care, King's College Hospital NHS Foundation Trust for services to critical care, particularly during COVID-19

Professor Tamas Szakmany, critical care consultant, Royal Gwent Hospital forservices to the NHS during COVID-19

Other health and social care professionals have been honoured with OBEs.

Prof Partha Kar, a consultant and endocrinologist at Portsmouth Hospitals NHS Trust, was honoured with an OBE for services to people with diabetes, and told Medscape News UK he was "humbled and grateful for all the love and support I have received from those living with diabetes".

Prof Kar, a national specialist adviser on diabetes care for NHS England, pioneered the use of continuous glucose monitoring devices in the NHS.

He added that it had been "a long way from growing up in Kolkata, India, to having one of the highest honours in the UK".

Among other OBE recipients were:

Prof Wendy Bickmore, director of the Medical Research Council's Human Genetics Unit at the University of Edinburgh

Prof Wendy Burn, president of the Royal College of Psychiatrists

Prof Ian Finlay, consultant surgeon at Glasgow Royal Infirmary

Usha Goswami, professor of cognitive developmental neuroscience at the University of Cambridge

Anthony Campbell, honorary research professor at Cardiff University

Robert Champion, founder of the prostate cancer charity, Bob Champion Cancer Trust

Dr Shikandhini Kanagasundrem, director, infection prevention and control and consultant microbiologist at the Princess Alexandra Hospital NHS Trust

Harjinder Kaur Kandola, chief executive, Barnet, Enfield and Haringey Mental Health NHS Trust, for services to mental health, particularly during the COVID-19 response

Francesca Gabrielle Happe, professor of cognitive neuroscience at King's College London, for services to the study of autism

Dr Timothy Ho, medical director at Frimley Health NHS Foundation Trust, for services to the NHS during COVID-19

Stephen Holmes, service director for adult social care at Northumberland County Council for services during the pandemic

Dr Gareth Hynes, specialty registrar at Oxford University Hospitals NHS Foundation Trust, for services to medical education during COVID-19

Dr Michael Paul Weekes, infectious diseases clinician at Cambridge University Hospitals NHS Foundation Trust

Michelle Johnson, chief nurse at the Whittington Health NHS Trust, for services to nursing, particularly during the pandemic

Sara Jane Robertson, matron at the Neonatal Intensive Care Unit at Ashford and St Peter's Hospitals NHS Foundation Trust, for services to nursing during COVID-19

Ramani Moonesinghe, professor of perioperative medicine and consultant anaesthetist, University College London for services to anaesthesia, perioperative, and critical care

Paul Charles Tunstell, associate chief pharmacist at Guy's and St Thomas' NHS Foundation Trust for services during the COVID-19 pandemic

Professor ChrisMoran,National Clinical Director for Trauma, NHS England and NHS Improvementforservices to trauma surgery

"As we begin a new year and continue to come together to fight this virus, may their service and stories be an inspiration to us all," Mr Johnson commented.

Visit link:
Health and Social Care Professionals Recognised in New Year Honours - Medscape

PGIMER-Chandigarh geared up to vaccinate 12,000 healthcare workers – Sify

Chandigarh, Dec 31 (IANS) The PGIMER has chalked out the plan to undertake vaccination against coronavirus of over 12,000 healthcare workers and all requisites are in place to start the process in January 2021, its Director Jagat Ram said here on Thursday.

A task force has also been set up to monitor the storage, infrastructure and manpower requirements and multiple centres created for the vaccination drive, he added.

Dr Jagat Ram also lauded the unwavering commitment and courage of the team from the Postgraduate Institute of Medical Education and Research (PGIMER) in combating corona scourge through 2020.

"The institute has been steadfast in serving COVID-19 patients across the region from day one. Till date, PGIMER has been able to provide treatment to over 3,000 COVID-19 patients, mostly with moderate to severe symptoms."

The PGIMER also contributed substantially to contain the spread of coronavirus by creating round-the-clock testing facilities and conducting around 1,30,000 RT-PCR tests, over 10,000 Genexpert and 6,000 rapid antigen tests (RATs) till date.

In addition, over 60 labs have been established under the mentorship of the PGI.

The renowned institute was selected to undertake one of the trials for various potential drugs for COVID-19, including second and third phases of human clinical trials of 'Covishield' for which the third phase is underway, Jagat Ram told the media.

"Though it was very challenging, but we tried our best to provide patient care services to non-COVID emergency patients reporting from all north Indian states as well, including OPD care to around 10 lakh non-COVID patients and IPD care to another 55,000-odd patients.

"Besides, the institute has been providing OPD services to patients through tele-consultation. A total of 2,11,610 patients have been provided consultation and treatment since its inception in May 2020."

Detailing other milestones, Dr Jagat Ram said that the PGIMER was honoured for the fourth time in a row with national award in 'Best Hospital' category for outstanding contribution towards promotion of cadaver organ donation.

It ranked second in the National Institutional Ranking Framework in the medical category for the third consecutive year.

THE PGIMER chief said that the construction of Advanced Neurosciences Centre and Mother and Child Care Centre was progressing well and hoped to make them operational by the end of 2021.

"Due to lockdown restrictions and non-availability of labourers, work was affected for almost two months, but we tried to cover up the loss when things got back on track. We are now satisfied with the pace of construction," the Director said.

Costing an estimated Rs 495.31 crore, the neurosciences centre is a 300-bed facility for timely, affordable and advanced treatment for neurological and neuroscience disorders.

Costing an estimated Rs 485 crore, the Mother and Child Care Centre is a 300-bed unit for improving obstetric and neonatal tertiary care.

PGIMER's satellite centre at Sangrur in Punjab is now functional, with its OPDs boosting healthcare in the area and easing patient load from that there.

"We are striving hard to make it fully functional in the coming year," the Director added.

--IANS

vg/tsb

Read the original here:
PGIMER-Chandigarh geared up to vaccinate 12,000 healthcare workers - Sify

Cancer patients to be offered test that tailors treatments to their genetics to avoid toxic side-effects – Telegraph.co.uk

Professor Dame Sue Hill, chief scientific officer for England and senior officer for genomics at NHS England, said the rollout marks "an important moment" for how genomics can improve the safety of cancer treatments.

She said: "As our understanding of the role our DNA plays in disease grows, we will be able to use this approach to help develop personalised treatments for other conditions and embed genomics into routine care."

Dr Simon Vincent, research director at Breast Cancer Now, said the test is a "welcome step" towards ensuring the "kindest" modes of treatment are used.

The test works by detecting variants within a specific gene, known as DPYD, which are likely to mean a patient has a lower level of the enzyme needed to break down cancer drugs in the body, leaving them exposed to higher levels of toxicity.

John McGuire, 71, from London, who is undergoing chemotherapy for colorectal cancer at Guy's Hospital, was put on a lower dose after being found to have the form of the gene.

Mr McGuire, who is halfway through treatment which aims to cure his cancer, said: "I'm delighted with the treatment I have received from the team at Guy's Hospital and have had little to no side-effects from my treatment... I think I am going to be really happy with the outcome."

It marks the latest in a series of innovations and genomic discoveries adopted by the NHS to deliver personalised cancer care.

Cancer survival rates are already at a record high, but the NHS Long Term Plan aims to catch three-quarters of tumours at an early stage, when they are easier to treat.

See more here:
Cancer patients to be offered test that tailors treatments to their genetics to avoid toxic side-effects - Telegraph.co.uk